Erschienen in:
01.12.2021 | Palliative and Supportive Care (MP Davis, Section Editor)
Treating Chronic Pain with Buprenorphine—The Practical Guide
verfasst von:
Amy A. Case, Justin Kullgren, Sidra Anwar, Sandra Pedraza, Mellar P. Davis
Erschienen in:
Current Treatment Options in Oncology
|
Ausgabe 12/2021
Einloggen, um Zugang zu erhalten
Opinion statement
Buprenorphine has unique and favorable pharmacological properties that make it useful in a variety of clinical scenarios. It has been recommended to consider buprenorphine first-line opioid for chronic pain, especially in the elderly as it may be associated with less cognitive impairment, falls, sexual dysfunction, and sarcopenia when compared with schedule II opioids. It may be useful in patients with comorbid substance use disorder or non-medical opioid use, as there is less risk of misuse, euphoria and it may improve mood. When used to treat opioid use disorder, the training and waiver was recently waived for licensed practitioners with a DEA and any provider may prescribe buprenorphine. For many reasons outlined in this article, the popularity of using buprenorphine for analgesia continues to grow and a practitioner should consider this as an excellent and safe option for chronic pain.